MRI guided prostate biopsy using a specialized needle holder frame
Official title: Magnetic Resonance Imaging Guided Prostate Biopsy
Run by Brigham and Women's Hospital · NCT06302595 · Data updated 2026-11-12
This study is testing a new needle holder frame during MRI-guided prostate biopsies to see if it can help doctors take more accurate tissue samples from suspicious areas.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years and up |
| Sex | Men only |
| Enrollment | 15 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | August 24, 2023 |
| Main results expected | June 2026 |
| Study ends | June 2026 |
| Registry record updated | December 3, 2025 |
| Trial ID | NCT06302595 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include men over 30 with abnormal PSA levels or suspicious lesions on prostate MRI.
✕Probably not a fit
Patients with contraindications to MRI or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility of using a needle holder frame during MRI-guided prostate biopsy procedures to enhance the accuracy of tissue sampling from suspicious areas identified on MRI. Participants who have already undergone a standard clinical prostate MRI will have the biopsy performed using this investigational device instead of a conventional template. The procedure will be conducted under monitored anesthesia or sedation, ensuring patient comfort while the biopsy is performed. The study aims to determine if this new approach can be safely integrated into routine clinical practice.
Why it matters
Potential benefit: If successful, this method could improve the accuracy and safety of prostate biopsies, leading to better diagnosis and treatment of prostate cancer.
How similar studies have gone: Other studies have shown promising results with MRI-guided biopsy techniques, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Either an abnormal serum prostate-specific antigen (PSA) level (\> 4ng/Ml) or a palpable nodule in the prostate on digital rectal examination or prostate MRI suspicious lesion.. * Diagnostic MRI of the prostate gland. * Age \> 30 years * Signed informed consent. * No contra-indications to MRI, i.e. no cardiac pacemaker. * No recent or ongoing active ischemic heart disease. Exclusion Criteria: * Inability to give informed consent. * Contra-indications to MRI- cardiac pacemaker, inner ear implants, non-MR compatible intracranial aneurysm clips. * Recent or ongoing active ischemic heart disease such as recent or ongoing angina.
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Kemal Tuncali, MD — Brigham and Women's Hospital
- Study coordinator: Kemal Tuncali, MD
- Email: ktuncali@bwh.harvard.edu
- Phone: (617) 732-7631
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Delayed PSMA PET/CT to improve detection of significant prostate cancer before biopsy
This study tests whether adding a delayed (2–3 hour) PSMA PET/CT scan improves detection of clinically significant prostate cancer in treatment‑naïve men who are awaiting biopsy compared with the standard 60‑minute scan.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Training Independent Muscle Activation From a Common Source
A new surgical approach plus home training tests whether people with recent amputations or revision surgeries can gain improved muscle control.
-
Activity after Spinal Surgery Engagement
This trial tests whether a behavioral program helps people recover by being more physically active after lumbar spine decompression surgery.
-
Reach and Engagement of Genetic Education, Risk Assessment, and Testing Feasibility (GENET) for PDAC risk
This study tests whether online education plus a phone call from PanCAN helps Black, Latino/a, and Medicaid-enrolled people in Massachusetts learn about genetic and multi-cancer early detection testing and decide about getting tested.
-
Burnout and Safety in Home Hospital vs Brick-and-Mortar Hospitals
This study tests whether frontline clinicians in home hospital programs experience different burnout levels and workplace violence than those in traditional inpatient hospitals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.